These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38044231)

  • 41. Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus.
    Enocsson H; Wirestam L; Dahle C; Padyukov L; Jönsen A; Urowitz MB; Gladman DD; Romero-Diaz J; Bae SC; Fortin PR; Sanchez-Guerrero J; Clarke AE; Bernatsky S; Gordon C; Hanly JG; Wallace DJ; Isenberg DA; Rahman A; Merrill JT; Ginzler E; Alarcón GS; Chatham WW; Petri M; Khamashta M; Aranow C; Mackay M; Dooley MA; Manzi S; Ramsey-Goldman R; Nived O; Steinsson K; Zoma AA; Ruiz-Irastorza G; Lim SS; Kalunian KC; Inanc M; van Vollenhoven RF; Ramos-Casals M; Kamen DL; Jacobsen S; Peschken CA; Askanase A; Stoll T; Bruce IN; Wetterö J; Sjöwall C
    J Autoimmun; 2020 Jan; 106():102340. PubMed ID: 31629628
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups.
    Massias JS; Smith EMD; Al-Abadi E; Armon K; Bailey K; Ciurtin C; Davidson J; Gardner-Medwin J; Haslam K; Hawley DP; Leahy A; Leone V; McErlane F; Mewar D; Modgil G; Moots R; Pilkington C; Ramanan AV; Rangaraj S; Riley P; Sridhar A; Wilkinson N; Beresford MW; Hedrich CM
    Lupus; 2020 Apr; 29(5):474-481. PubMed ID: 32233733
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of the Systemic Lupus International Collaborating Clinics Frailty Index and Damage Accrual in Longstanding Systemic Lupus Erythematosus.
    Lima K; Legge A; Hanly JG; Lee J; Song J; Chung A; Ramsey-Goldman R
    Arthritis Care Res (Hoboken); 2023 Mar; 75(3):578-584. PubMed ID: 34590445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New classification criteria for systemic lupus erythematosus correlate with disease activity.
    Anić F; Zuvić-Butorac M; Stimac D; Novak S
    Croat Med J; 2014 Oct; 55(5):514-9. PubMed ID: 25358884
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
    Ward MM; Marx AS; Barry NN
    J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Charlson Comorbidity Index Is Related to Organ Damage in Systemic Lupus Erythematosus: Data from KORean lupus Network (KORNET) Registry.
    Kim SK; Choe JY; Lee SS
    J Rheumatol; 2017 Apr; 44(4):452-458. PubMed ID: 28298561
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The SLICC-FI Predicts Damage Accrual in SLE Patients. Data From the Almenara Lupus Cohort.
    Elera-Fitzcarrald C; Gamboa-Cárdenas RV; Reatégui-Sokolova C; Pimentel-Quiroz V; Rodriguez-Bellido Z; Pastor-Asurza CA; Perich-Campos R; Alarcón GS; Ugarte-Gil MF
    Lupus; 2022 Nov; 31(13):1666-1670. PubMed ID: 36165429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic lupus erythematosus among male patients in Malaysia: how are we different from other geographical regions?
    Shaharir SS; Kadir WDA; Nordin F; Bakar FA; Ting MWH; Jamil A; Mohd R; Wahab AA
    Lupus; 2019 Jan; 28(1):137-144. PubMed ID: 30458692
    [TBL] [Abstract][Full Text] [Related]  

  • 49. External validation of the Systemic Lupus International Collaborating Clinics Frailty Index as a predictor of adverse health outcomes in systemic lupus erythematosus.
    Legge A; Malone A; Hanly JG
    Rheumatology (Oxford); 2022 May; 61(5):1919-1927. PubMed ID: 34410347
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus.
    Harden OC; Hammad SM
    Front Immunol; 2020; 11():586737. PubMed ID: 33101319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort.
    Ugarte-Gil MF; Acevedo-Vásquez E; Alarcón GS; Pastor-Asurza CA; Alfaro-Lozano JL; Cucho-Venegas JM; Segami MI; Wojdyla D; Soriano ER; Drenkard C; Brenol JC; de Oliveira e Silva Montandon AC; Costallat LT; Massardo L; Molina-Restrepo JF; Guibert-Toledano M; Silveira LH; Amigo MC; Barile-Fabris LA; Chacón-Díaz R; Esteva-Spinetti MH; Pons-Estel GJ; McGwin G; Pons-Estel BA;
    Ann Rheum Dis; 2015 Jun; 74(6):1019-23. PubMed ID: 24525909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Childhood Systemic Lupus Erythematosus: Presentation, management and long-term outcomes in an Australian cohort.
    Cann MP; Sage AM; McKinnon E; Lee SJ; Tunbridge D; Larkins NG; Murray KJ
    Lupus; 2022 Feb; 31(2):246-255. PubMed ID: 35037500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical composite measures of disease activity and damage used to evaluate patients with systemic lupus erythematosus: A systematic literature review.
    Castrejón I; Rúa-Figueroa I; Rosario MP; Carmona L
    Reumatol Clin; 2014; 10(5):309-20. PubMed ID: 25022441
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuropsychiatric systemic lupus erythematosus: association with global disease activity.
    Morrison E; Carpentier S; Shaw E; Doucette S; Hanly JG
    Lupus; 2014 Apr; 23(4):370-7. PubMed ID: 24457602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus.
    Rivest C; Lew RA; Welsing PM; Sangha O; Wright EA; Roberts WN; Liang MH; Karlson EW
    J Rheumatol; 2000 Mar; 27(3):680-4. PubMed ID: 10743808
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Prognostic Nutritional Index and Nutritional Risk Index Are Associated with Disease Activity in Patients with Systemic Lupus Erythematosus.
    Correa-Rodríguez M; Pocovi-Gerardino G; Callejas-Rubio JL; Fernández RR; Martín-Amada M; Cruz-Caparros MG; Ortego-Centeno N; Rueda-Medina B
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30884776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebral hypoperfusion detected by SPECT in patients with systemic lupus erythematosus is related to clinical activity and cumulative tissue damage.
    López-Longo FJ; Carol N; Almoguera MI; Olazarán J; Alonso-Farto JC; Ortega A; Monteagudo I; González CM; Carreño L
    Lupus; 2003; 12(11):813-9. PubMed ID: 14667096
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of cutaneous disease activity in early lupus and its correlation with quality of life: a cross-sectional study.
    Hinduja N; Mv P; Padhee S; Maikap D; Padhan P; Kar HK; Misra R; Srinivas CR; Ahmed S
    Rheumatol Int; 2023 Oct; 43(10):1835-1840. PubMed ID: 37310437
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lupus low disease activity state within 12 months is associated with favourable outcomes in severely active systemic lupus erythematosus.
    Kikuchi J; Hanaoka H; Saito S; Oshige T; Hiramoto K; Kaneko Y; Takeuchi T
    Rheumatology (Oxford); 2022 Aug; 61(9):3777-3791. PubMed ID: 35015824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.